Day Kenneth, Waite Lindsay L, Thalacker-Mercer Anna, West Andrew, Bamman Marcas M, Brooks James D, Myers Richard M, Absher Devin
Genome Biol. 2013;14(9):R102. doi: 10.1186/gb-2013-14-9-r102.
DNA methylation is an epigenetic modification that changes with age in human tissues, although the mechanisms and specificity of this process are still poorly understood. We compared CpG methylation changes with age across 283 human blood, brain, kidney, and skeletal muscle samples using methylation arrays to identify tissue-specific age effects.
We found age-associated CpGs (ageCGs) that are both tissue-specific and common across tissues. Tissue-specific age CGs are frequently located outside CpG islands with decreased methylation, and common ageCGs show the opposite trend. AgeCGs are significantly associated with poorly expressed genes, but those with decreasing methylation are linked with higher tissue-specific expression levels compared with increasing methylation. Therefore, tissue-specific gene expression may protect against common age-dependent methylation. Distinguished from other tissues, skeletal muscle age CGs are more associated with expression, enriched near genes related to myofiber contraction, and closer to muscle-specific CTCF binding sites. Kidney-specific ageCGs are more increasingly methylated compared to other tissues as measured by affiliation with kidney-specific expressed genes. Underlying chromatin features also mark common and tissue-specific age effects reflective of poised and active chromatin states, respectively. In contrast with decreasingly methylated ageCGs, increasingly methylated ageCGs are also generally further from CTCF binding sites and enriched within lamina associated domains.
Our data identified common and tissue-specific DNA methylation changes with age that are reflective of CpG landscape and suggests both common and unique alterations within human tissues. Our findings also indicate that a simple epigenetic drift model is insufficient to explain all age-related changes in DNA methylation.
DNA甲基化是一种表观遗传修饰,在人体组织中会随年龄变化,尽管该过程的机制和特异性仍知之甚少。我们使用甲基化阵列比较了283个人类血液、大脑、肾脏和骨骼肌样本中与年龄相关的CpG甲基化变化,以确定组织特异性的年龄效应。
我们发现了与年龄相关的CpG(ageCGs),它们既具有组织特异性又在不同组织中普遍存在。组织特异性的年龄相关CpG通常位于CpG岛之外,甲基化水平降低,而普遍存在的ageCGs则呈现相反趋势。AgeCGs与低表达基因显著相关,但甲基化水平降低的那些与甲基化水平升高相比,与更高的组织特异性表达水平相关。因此,组织特异性基因表达可能预防常见的年龄依赖性甲基化。与其他组织不同,骨骼肌ageCGs与表达的关联更强,在与肌纤维收缩相关的基因附近富集,并且更接近肌肉特异性CTCF结合位点。通过与肾脏特异性表达基因的关联测量,肾脏特异性ageCGs与其他组织相比甲基化程度增加得更多。潜在的染色质特征也分别标记了反映平衡和活跃染色质状态的常见和组织特异性年龄效应。与甲基化水平降低的ageCGs相反,甲基化水平升高的ageCGs通常也离CTCF结合位点更远,并在核纤层相关结构域内富集。
我们的数据确定了与年龄相关的常见和组织特异性DNA甲基化变化,这些变化反映了CpG景观,并暗示了人体组织内的共同和独特改变。我们的研究结果还表明,一个简单的表观遗传漂变模型不足以解释DNA甲基化中所有与年龄相关的变化。